Brief: GT Biopharma's Camelid TriKE® Nanobody Platform Highlighted At ESMO Congress 2021
20/09/2021 12:35
Sept 20 (Reuters) - GT Biopharma Inc GTBP.O :
* GT BIOPHARMA'S NEXT GENERATION CAMELID TRIKE® NANOBODY
PLATFORM
HIGHLIGHTED AT ESMO CONGRESS 2021
Source text for Eikon: ID:nPn5sktg9a
Further company coverage: GTBP.O
((Reuters.Briefs@thomsonreuters.com;))